Review of Crystallization in Nanoconfinement Created by Emulsions and Microemulsions for Pharmaceutical Applications
Source abstract
Abstract
In the creation of solid dosage forms in the pharmaceutical industry, crystallization has a large impact on the properties of the payloads and matrix, such as melting point, polymorphic form, and crystallinity. Control of the crystallization of the drugs and the material in the matrix using a process of crystallization under confinement to achieve desirable properties is challenging. Emulsions allow the encapsulation of drugs for use in pharmaceutical applications. The limited volume available for crystallization under confinement in emulsions has a significant effect on the crystallization of the payloads and matrices. We discuss here advances in improving the characteristics of pharmaceutical products through the use of crystallization under confinement created by an emulsion. We also review the methods for preparing emulsions, in which the droplets act as a template for the crystallization under confinement. In addition, the influences of crystallization in emulsions on solubility, release profile of payloads, permeability, and polymorphism are reviewed.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Crystallization and Solubility Studies · Analytical Chemistry and Chromatography
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biomolecular Engineering, School of Energy Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Rayong 21210, Thailand
Department of Materials Science and Engineering, School of Molecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Rayong 21210, Thailand
Funding
Vidyasirimedhi Institute of Science and Technology
References (69)
Show source-provided references
1. 10.3390/pharmaceutics1203021410.3390/pharmaceutics12030214 ↗
2. 10.3390/pharmaceutics1210099510.3390/pharmaceutics12100995 ↗
3. 10.1016/j.progpolymsci.2015.10.00710.1016/j.progpolymsci.2015.10.007 ↗
4. 10.1002/adma.20200106810.1002/adma.202001068 ↗
5. 10.1039/C3CS60234F10.1039/C3CS60234F ↗
6. 10.1021/acs.langmuir.9b0221510.1021/acs.langmuir.9b02215 ↗
7. 10.1002/chem.20200124610.1002/chem.202001246 ↗
8. 10.1016/j.ejpb.2011.11.00510.1016/j.ejpb.2011.11.005 ↗
9. 10.2147/IJN.S2876110.2147/IJN.S28761 ↗
10. 10.1208/s12249-012-9876-210.1208/s12249-012-9876-2 ↗
11. 10.1021/acs.molpharmaceut.8b0117210.1021/acs.molpharmaceut.8b01172 ↗
12. 10.1016/S0032-3861(01)00394-910.1016/S0032-3861(01)00394-9 ↗
13. 10.1002/marc.20060033110.1002/marc.200600331 ↗
14. 10.1039/c3py21098g10.1039/c3py21098g ↗
15. 10.1002/adma.20060175910.1002/adma.200601759 ↗
16. 10.1002/adma.20060194510.1002/adma.200601945 ↗
17. 10.1002/anie.20191434310.1002/anie.201914343 ↗
18. 10.1021/cg101200f10.1021/cg101200f ↗
19. 10.1021/cg101597q10.1021/cg101597q ↗
20. 10.3390/cryst103019510.3390/cryst1030195 ↗
21. 10.1039/C5CE01202C10.1039/C5CE01202C ↗
22. 10.1016/j.addr.2018.05.00210.1016/j.addr.2018.05.002 ↗
23. 10.1007/s40005-017-0357-110.1007/s40005-017-0357-1 ↗
24. 10.1016/j.ijpharm.2012.07.01510.1016/j.ijpharm.2012.07.015 ↗
25. 10.3390/pharmaceutics1003007410.3390/pharmaceutics10030074 ↗
26. 10.1021/js980403l10.1021/js980403l ↗
27. 10.3109/10717544.2014.89605810.3109/10717544.2014.896058 ↗
28. 10.1016/j.ejpb.2008.12.00910.1016/j.ejpb.2008.12.009 ↗
29. 10.1016/j.colsurfb.2021.11176410.1016/j.colsurfb.2021.111764 ↗
30. 10.1002/anie.20210344410.1002/anie.202103444 ↗
31. 10.1002/mame.20210010210.1002/mame.202100102 ↗
32. 10.1016/j.jcis.2019.04.08510.1016/j.jcis.2019.04.085 ↗
33. 10.1039/C9BM01872G10.1039/C9BM01872G ↗
34. 10.1016/j.apenergy.2013.08.04810.1016/j.apenergy.2013.08.048 ↗
35. 10.1021/cg401298210.1021/cg4012982 ↗
36. 10.1021/cg501222n10.1021/cg501222n ↗
37. 10.1002/cphc.20040052710.1002/cphc.200400527 ↗
38. 10.1002/adhm.20160026610.1002/adhm.201600266 ↗
39. 10.1016/j.xphs.2017.06.00510.1016/j.xphs.2017.06.005 ↗
40. Deaconu M. · UPB Sci. Bull. B: Chem. Mater. Sci. · 2018 · 80 · 3
41. 10.1002/jps.2196410.1002/jps.21964 ↗
42. 10.1080/02652048.2019.157926510.1080/02652048.2019.1579265 ↗
43. 10.1021/mp900221e10.1021/mp900221e ↗
44. 10.1016/j.ijpharm.2011.03.01810.1016/j.ijpharm.2011.03.018 ↗
45. 10.1016/j.biomaterials.2011.05.07910.1016/j.biomaterials.2011.05.079 ↗
46. 10.1016/j.cis.2012.03.00210.1016/j.cis.2012.03.002 ↗
47. 10.1039/C6FO01579D10.1039/C6FO01579D ↗
48. 10.1016/j.xphs.2018.03.02910.1016/j.xphs.2018.03.029 ↗
49. 10.1016/j.colsurfb.2013.06.01310.1016/j.colsurfb.2013.06.013 ↗
50. 10.3109/03639045.2014.93808210.3109/03639045.2014.938082 ↗
51. 10.1016/j.ijpharm.2003.11.02910.1016/j.ijpharm.2003.11.029 ↗
52. 10.1039/C6PY00344C10.1039/C6PY00344C ↗
53. 10.1002/macp.20110052910.1002/macp.201100529 ↗
54. 10.1038/ncomms1059910.1038/ncomms10599 ↗
55. 10.1038/s41467-018-05396-x10.1038/s41467-018-05396-x ↗
56. 10.1016/j.jconrel.2005.06.00410.1016/j.jconrel.2005.06.004 ↗
57. 10.1021/cg025568t10.1021/cg025568t ↗
58. 10.1016/j.foodchem.2014.08.11310.1016/j.foodchem.2014.08.113 ↗
59. 10.1007/s11746-003-0765-210.1007/s11746-003-0765-2 ↗
60. 10.1021/cg050304310.1021/cg0503043 ↗
61. 10.1021/la702763e10.1021/la702763e ↗
62. Magdassi, S.; Netivi, H.; Goshen, K. Organic Nanoparticles Obtained from Microemulsions by Solvent Evaporation EP2061583B1, 2019.
63. Li, F.; Li, C. Method for Preparing Docetaxel Drug-Loaded Nanoparticles with Polylactic Acid/Hydroxyglycollic Acid Copolymer as Material. CN105055312A, 2015.
64. Zhao, L.; Wei, Y.; Zhao, Y.; Huang, Y.; Wang, P. Solid Lipid Nanoparticle or Liposome and Preparation Method Thereof. CN104173290A, 2014.
65. Kaufman, R. C. Nanoparticle Compositions and Methods as Carriers of Nutraceutical Factors Across Cell Membranes and Biological Barriers. US9925149B2, 2014.
66. Planchette, C.; Mercuri, A. Self-emulsifying Nanosuspensions as Drug Delivery Systems (SENDDS). GB2541387A, 2015.
67. 10.1002/masy.20105100410.1002/masy.201051004 ↗
68. 10.1039/c1sm06156a10.1039/c1sm06156a ↗
69. 10.1021/acsami.0c0799310.1021/acsami.0c07993 ↗